NCT00919399View on ClinicalTrials.gov

Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Breast Neoplasms
Interventions
DRUG

Exemestane

25mg a day during 4 months

DRUG

tamoxifen

One 20 mg tablet a day started 1 week after the first Aromasine intake

Trial Locations (2)

Unknown

CHU de Toulouse Rangueil, Toulouse

Institut Claudius Regaud, Toulouse

All Listed Sponsors
collaborator

PHARMACIA SAS

UNKNOWN

lead

Institut Claudius Regaud

OTHER

NCT00919399 - Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant | Biotech Hunter | Biotech Hunter